---
title: "COL1A2"
date: 2023-05-12 00:00:00
layout: post
categories: Gene
summary: "# Information About Gene COL1A2"
tags: ['COL1A2', 'OsteogenesisImperfecta', 'EhlersDanlosSyndrome', 'TypeICollagen', 'GeneticDisorders', 'Mutation', 'Treatment', 'Prognosis']
---

# Information About Gene COL1A2

## Genetic Position

The COL1A2 gene is located on chromosome 7 at the position q21.3.

## Pathology

Mutations in the COL1A2 gene are associated with several genetic disorders, including osteogenesis imperfecta (OI) and Ehlers-Danlos syndrome (EDS). OI is caused by mutations that result in reduced or altered production of type I collagen, which is mainly encoded by the COL1A2 gene. EDS is a connective tissue disorder that can be caused by mutations affecting the structure or expression of type I collagen.

## Function

The COL1A2 gene encodes type I collagen, which is the most abundant protein in the extracellular matrix of many tissues, including bone, skin, and tendons. Type I collagen provides structure and support to these tissues and is important for their development, growth, and repair.

## External IDs and Aliases

- HGNC: 2201
- NCBI Entrez: 1278
- Ensembl: ENSG00000108821
- OMIM: 120160
- UniProtKB/Swiss-Prot: P08123
- Aliases: OI4, OTTHUMP00000164630

## AA Mutation List and Mutation Type with dbSNP ID

- p.Gly198Ser - Missense - rs121912688
- p.Ala997Thr - Missense - rs150824602
- p.Gly775Ser - Missense - rs150185293
- p.Arg312Cys - Missense - rs267607216
- p.Lys880Glu - Missense - rs1057518922

## Somatic SNVs/InDels with dbSNP ID

- c.688G>A - rs767515487
- c.1180C>T - rs754845024
- c.888G>A - rs753740878
- c.223C>T - rs766996308
- c.425C>T - rs770728169

## Related Disease

- Osteogenesis Imperfecta
- Ehlers-Danlos Syndrome
- Osteoporosis

## Treatment and Prognosis

There is no cure for osteogenesis imperfecta or Ehlers-Danlos syndrome, but treatment can help manage symptoms. This can include physical therapy, medications to increase bone density, and surgery for severe bone deformities. The prognosis depends on the specific type and severity of the disease.

## Drug Response

There is currently no drug that targets the COL1A2 gene specifically, but some drugs used for osteoporosis or bone disorders may be prescribed for osteogenesis imperfecta and other related diseases.

## Related Papers

- Subject: Osteogenesis Imperfecta
  - Author: Forlino A, Marini JC
  - DOI: 10.1038/s41578-018-0027-0
- Subject: Ehlers-Danlos Syndrome
  - Author: Malfait F, Francomano C, Byers P, Belmont J, et al.
  - DOI: 10.1038/ng.3658
- Subject: COL1A2 Gene Mutations in Osteogenesis Imperfecta
  - Author: Rauch F, Glorieux FH
  - DOI: 10.1055/s-2005-915099

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**